Plasma and urine nitric oxide concentrations in horses given a low dose of endotoxin

American Journal of Veterinary Research

Volumn 60, Issue 8, 1999, Pages 969-976

  Bueno, Aloisio C ^a   Seahorn, Thomas L ^a   Cornick Seahorn, Janyce ^a   Horohov, David W ^a   Moore, Rustin M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; ENDOTOXIN; ENDOTOXIN, ESCHERICHIA COLI; FIBRINOGEN; FORMAZAN; INTERLEUKIN 1; INTERLEUKIN 6; MTT FORMAZAN; NITRIC OXIDE; TETRAZOLIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BIOSYNTHESIS; BLOOD; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CHEMISTRY; CHEMOLUMINESCENCE; ENDOTOXEMIA; ENTEROBACTER INFECTION; FEMALE; HEART RATE; HORSE; HORSE DISEASE; IMMUNOLOGY; METABOLISM; URINE;

ANIMALS; BLOOD GAS ANALYSIS; BLOOD PRESSURE; CHEMILUMINESCENT MEASUREMENTS; CYTOKINES; ENDOTOXEMIA; ENDOTOXINS; ESCHERICHIA COLI INFECTIONS; FEMALE; FIBRINOGEN; FORMAZANS; HEART RATE; HORSE DISEASES; HORSES; INTERLEUKIN-1; INTERLEUKIN-6; NITRIC OXIDE; TETRAZOLIUM SALTS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033172858     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (60)

1. Morris DD. Endotoxemia in horses: a review of cellular and humoral mediators involved in its pathogenesis. J Vet Intern Med 1991;5:167-181.
2. Moore JN, Morris DD. Endotoxemia and septicemia in horses: experimental and clinical correlates. J Am Vet Med Assoc 1992;200:1903-1914.
3. King JN, Gerring EL. Detection of endotoxin in cases of equine colic. Vet Rec 1988;123:269-271.
4. Green EM, Adams HR. New perspectives in circulatory shock: pathophysiologic mediators of the mammalian response to endotoxemia and sepsis. J Am Vet Med Assoc 1992;200:1834-1841.
5. Olson NC, Hellyer PW, Dodam JR. Mediators and vascular effects in response to endotoxin. Br Vet J 1995;151:489-522.
6. Morris DD, Moore JN, Crowe N. Serum tumor necrosis factor activity in horses with colic attributable to gastrointestinal tract disease. Am J Vet Res 1991;52:1565-1569.
7. MacKay RJ, King RR, Dankert JR, et al. Cytotoxic tumor necrosis factor activity produced by equine alveolar macrophages: preliminary characterization. Vet Immunol Immunopathol 1991;29: 1-30.
8. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;288:373-376.
9. Green LC, Tannenbaum SR, Goldman R. Nitrate synthesis in germ free and conventional rats. Science 1981;212:56-68.
10. Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992;65:287-346.
11. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-142.
12. Palmer RMH, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelial-derived relaxing factor. Nature 1987;327:524-526.
13. Parratt JR. Nitric oxide in sepsis and endotoxemia. J Antimicrob Chemother 1998;41:31-39.
14. Adams HR. Nitric oxide: pathogenic roles in circulatory shock, in Proceedings. 12th Am Coll Vet Intern Med Forum 1994; 752-753.
15. Wright CE, Rees DD, Moncado S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26: 48-57.
16. Kubes P. Nitric oxide: a modulator of cell-cell interactions in the microcirculation. Georgetown, Tex: RG Landes Co, 1995;46-62.
17. Lancaster J. Role of nitric oxide in septic (endotoxemic) shock, in Proceedings. 12th Am Coll Vet Intern Med Forum 1994; 750-751.
18. Miller MJS, Clark DA. Nitric oxide synthase inhibition can initiate or prevent inflammation: role of enzyme source. Agents Actions Suppl 1994;41:231-232.
19. Wink DA, Vodovotz Y, Laval J, et al. The multifaceted roles of nitric oxide in cancer. Carcinogenesis 1998;19:711-721.
20. Ellis G, Adatia I, Yazdanpanah M, et al. Nitrite and nitrate analyses: a chemical biochemistry perspective. Clin Biochem 1998;31:195-220.
21. Epstein M, Goligorsky MS. Endothelium and nitric oxide in hepatorenal syndrome: a balance reset. J Nephrol 1997;10:120-135.
22. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214: 621-626.
23. Elliot J, Bryant CE, Soydan J. The role of nitric oxide in the response of equine digital veins to vasodilator and vasoconstrictor agents. Equine Vet J 1994;24:378-384.
24. Cosgwell AM, Johnson PJ, Adams HR. Evidence for endothelium-derived relaxing factor/nitric oxide in equine digital arteries. Am J Vet Res 1995;56:1637-1641.
25. Hinckley KA, Fearn S, Howard BR, et al. Glyceryl trinitrate enhances nitric oxide mediated perfusion within the equine hoof. J Endocrinol 1996;151:1-8.
26. Bird JL, Wells T, Platt D, et al. IL-1 beta induces the degradation of equine articular cartilage by a mechanism that is not mediated by nitric oxide. Biochem Biophys Res Comm 1997;238:81-85.
27. Moore RM, Venugopalan CS, Sedrish SA, et al. Role of endothelium and nitric oxide in the in vitro response of equine colonic venous rings to vasoconstrictor agents. Am J Vet Res 1997;58: 1145-1151.
28. Rakestraw PC, Snyder JR, Woliner MJ, et al. Involvement of nitric oxide in inhibitory neuromuscular transmission in equine jejunum. Am J Vet Res 1996;57:1206-1213.
29. Venugopalan CS, Moore RM, Holmes EP, et al. Role of endothelium and nitric oxide in the response of equine colonic arterial rings to vasoconstrictor agents. Vet Surg 1997;26:182-188.
30. Yu M, Wang Z, Robinson NE, et al. Inhibitory nerve distribution and mediation of NANC relaxation by nitric oxide in horse airways. J Appl Physiol 1994;76:334-339.
31. Frean SP, Bryant CE, Froling IL, et al. Nitric oxide production by equine articular cells in vitro. Equine Vet J 1997;29:98-102.
32. Moore RM, Muir WW, Bertone AL, et al. Characterization of the hemodynamic and metabolic alterations in the large colon of horses during low-flow ischemia and reperfusion. Am J Vet Res 1994; 55:1444-1453.
33. O'Neill SK, Triggle CR. Computerized data acquisition and analysis applied to chemiluminescence detection of nitric oxide in headspace gas. J Pharmacol Toxicol Meth 1993;29:217-221.
34. Durando MM, MacKay RJ, Linda S, et al. Effects of polymyxin B and Salmonella lymphimurium antiserum on horses given endotoxin intravenously. Am J Vet Res 1994;55:921-927.
35. MacKay RJ, Merritt AM, Zertuche JM, et al. Tumor necrosis factor activity in the circulation of horses given endotoxin. Am J Vet Res 1991;52:533-538
36. MacKay RJ, Lester GD. Induction of acute-phase cytokine, hepatocyte-stimulating factor/interleukin-6 in the circulation of horses treated with endotoxin. Am J Vet Res 1992;53:1285-1289.
37. 2) and interferon α/β present in post-endotoxin serum induce differentiation of murine MI myeloid leukemia cells. Exp Hematol 1989;17:1063-1066.
38. Nakai S, Mizuno K, Kaneta M, et al. A simple sensitive bioassay for detection of interleukin-1 using human melanoma A375 cell line. Biochem Biophys Res Commun 1988;154:1189-1196.
39. Weitzberg E, Rudehill A, Lundberg JM. Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 1993;233:85-94.
40. Petros A, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-1558.
41. Nicholson S, Bonecini-Almeida MG, Silva JRL, et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J Exp Med 1996;183:2293-2302.
42. Jungi TW, Adler H, Adler B, et al. Inducible nitric oxide synthase of macrophages. Present knowledge and evidence for species-specific regulation. Vet Immunol Immunopathol 1996;54:323-330.
43. Adler H, Frech B, Thony M, et al. Differential cytokine regulation of nitric oxide synthase in bovine and murine macrophages. J Immunol 1995;154:4710-4718.
44. MacMicking J, Xie Q, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol 1997;15:323-350.
45. Tsukahara Y, Moriaski T, Horita Y, et al. Expression of inducible nitric oxide synthase in circulating meutrophils of systemic inflammatory response syndrome and septic patients. World J Surg 1998;22:771-777.
46. Kilbourn RG, Jubran A, Gross SS, et al. Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990;172:1132-1138.
47. Clark ES, Gantley B, Moore JN. Effects of slow infusion of a low dosage of endotoxin on systemic haemodynamics in conscious horses. Equine Vet J 1991;23:18-21.
48. Morris DD, Crowe N, Moore JN. Correlation of clinical and laboratory data with serum tumor necrosis factor activity in horses with experimentally induced endotoxemia. Am J Vet Res 1990;51: 1935-1940.
49. Barton MH, Bruce EH, Moore JN, et al. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia. Am J Vet Res 1998;59:792-797.
50. Archer S. Measurement of nitric oxide in biological models. FASEB J 1993;7:349-360.
51. Cox RD, Frank CW. Determination of nitrate and nitrite in blood and urine by chemiluminescence. J Anal Toxicol 1982;6:148-152.
52. Zeballos GA, Bernstein RD, Thompson CI, et al. Pharmacodynamics of plasma nitrate/nitrite as an indication of nitric oxide formation in conscious dogs. Circulation 1995;91:2982-2988.
53. Kaiser L, Williams JE. Possible problems in measuring nitric oxide (lett). J Am Vet Med Assoc 1997;210:1584-1586.
54. - and cyclic guanosine monophosphate levels in patients with Bartter's syndrome: relationship to vascular reactivity. J Kidney Dis 1996;27:784-789.
55. Jesch NK, Dorger M, Enders G, et al. Expression of inducible nitric oxide synthase and formation of nitric oxide by alveolar macrophages: an interspecies comparison. Environ Health Perspect 1997;105(suppl):1297-1300.
56. Clark ES, Moore JN. The effects of a slow infusion of a low dosage of endotoxin in healthy horses. Equine Vet J 1989;7(suppl): 33-37.
57. Umans JG, Wylam ME, Samsel RW, et al. Effects of endotoxin in vivo on endothelial and smooth muscle function in rabbit and rat aorta. Am Rev Respir Dis 1993;148:1638-1645.
58. Julou-Schaeffer G, Gray GA, Fleming I, et al. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 1990;259:1038-1043.
59. Hussain SN, Abdul-Hussain MN, el-Dwairi Q. Exhaled nitric oxide as a marker for serum nitric oxide concentrations in acute endotoxemia. J Crit Care 1996;11:167-175.
60. Fox SW, Chow JW. Nitric oxide synthase expression in bone cells. Bone 1998;23:1-6.